C

ChromaDex Corp
D

CDXC

5.41000
USD
-0.28
(-4.92%)
مغلق
حجم التداول
13,703
الربح لكل سهم
0
العائد الربحي
-
P/E
277
حجم السوق
413,233,474
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BGI
    0.02000
    (1.69%)
    1.20000 USD
    J
    JAGX
    0.00810
    (0.94%)
    0.87420 USD
    L
    LYRA
    0.00790
    (4.00%)
    0.20520 USD
    S
    SNDL
    0.00500
    (0.28%)
    1.77000 USD
    V
    VVOS
    -0.11000
    (-3.42%)
    3.11000 USD
    المزيد
الأخبار
المقالات

العنوان: ChromaDex Corp

القطاع: Consumer Defensive
الصناعة: Packaged Foods
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.